Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
11.16
-0.95 (-7.84%)
At close: Nov 10, 2026, 4:00 PM EST
11.20
+0.04 (0.36%)
After-hours: Nov 10, 2026, 6:45 PM EST
Intellia Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $49 | Buy | Maintains | $49 | +339.07% | Nov 9, 2026 |
| J.P. Morgan | J.P. Morgan | Sell Reiterates $8 → $9 | Sell | Reiterates | $8 → $9 | -19.35% | Nov 9, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $29 → $27 | Buy | Maintains | $29 → $27 | +141.94% | Nov 6, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $15 | Hold | Maintains | $15 | +34.41% | Nov 6, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $15 | Hold | Maintains | $15 | +34.41% | Nov 6, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $17 → $16 | Hold | Reiterates | $17 → $16 | +43.37% | Nov 6, 2026 |
| Wedbush | Wedbush | Hold Maintains $13 | Hold | Maintains | $13 | +16.49% | Nov 6, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +124.01% | Nov 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.